Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002690083 | SCV002991509 | pathogenic | not provided | 2022-11-08 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs750135817, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gly77Glnfs*62) in the IFT43 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT43 are known to be pathogenic (PMID: 21378380, 28400947). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with IFT43-related conditions. |
Revvity Omics, |
RCV002690083 | SCV003813256 | uncertain significance | not provided | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005002870 | SCV005633354 | likely pathogenic | Cranioectodermal dysplasia 3; Short-rib thoracic dysplasia 18 with polydactyly; Retinitis pigmentosa 81 | 2023-12-29 | criteria provided, single submitter | clinical testing |